ADC Biotechnology

About:

ADC BIO is an innovative biotechnology company. Specialising in Antibody Drug Conjugates.

Website: http://www.adcbio.com/

Twitter/X: adcbio

Top Investors: Maven Capital Partners, Development Bank of Wales, Seneca Partners, Downing Ventures, Downing LLP

Description:

ADC Bio is developing new process technology to help drug developers meet conjugation process challenges in the testing and production of new antibody drug conjugate (ADC)-based anti cancer drugs. The technology signals faster, simpler and less costly development for an exciting new family of drugs.

Total Funding Amount:

16.3M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saint Asaph, Denbighshire, United Kingdom

Founded Date:

2010-01-01

Founders:

Charlie Johnson, David Evans

Number of Employees:

11-50

Last Funding Date:

2018-11-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai